Corcept Therapeutics, Inc.
(NASDAQ : CORT)

( )
CORT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 0.00%45.880.0%$167.43m
VRXValeant Pharmaceuticals International, Inc. -0.04%27.0714.1%$159.28m
ICLRICON plc 0.00%266.392.8%$142.73m
CTLTCatalent, Inc. -0.05%108.192.0%$117.41m
BHCBausch Health Cos., Inc. -0.04%27.070.0%$112.90m
HZNPHorizon Therapeutics Plc 0.00%91.105.4%$106.55m
JAZZJazz Pharmaceuticals Plc 0.00%144.302.1%$88.31m
UTHRUnited Therapeutics Corp. 0.00%213.9613.9%$83.03m
ARGXargenx SE 0.00%291.500.0%$68.34m
PRGOPerrigo Co. Plc 0.03%39.746.9%$50.64m
BRBRBellRing Brands, Inc. 0.04%25.930.0%$28.46m
PCRXPacira Biosciences, Inc. 0.00%64.089.8%$26.06m
CORTCorcept Therapeutics, Inc. 0.00%18.455.5%$21.72m
SAGESAGE Therapeutics, Inc. 0.00%42.937.6%$19.98m
IRWDIronwood Pharmaceuticals, Inc. 0.00%11.729.5%$19.47m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.